Vicarious Surgical Announces President Transition to Board Member Role
Vicarious Surgical (NYSE: RBOT) announced that Company President Randy Clark will transition to a Board Member role, effective April 25, 2025. As President, Clark led key business functions including product development, operations, clinical regulatory, quality affairs, and human resources.
During his tenure, Clark made significant contributions by:
- Developing manufacturing capabilities and strengthening supply chain
- Establishing key partnerships
- Implementing personnel realignment
- Streamlining business processes
- Formalizing workflows and standardizing procedures
CEO Adam Sachs acknowledged Clark's role in building a strong foundation for future growth. Clark will continue to provide strategic guidance as a Board member, ensuring his expertise remains available to the company while allowing for leadership evolution aligned with strategic and capital needs.
Vicarious Surgical (NYSE: RBOT) ha annunciato che il Presidente dell'Azienda, Randy Clark, passerà a un ruolo di Membro del Consiglio, con effetto dal 25 aprile 2025. In qualità di Presidente, Clark ha guidato funzioni aziendali chiave, tra cui lo sviluppo del prodotto, le operazioni, la regolamentazione clinica, le questioni di qualità e le risorse umane.
Durante il suo mandato, Clark ha dato contributi significativi attraverso:
- Sviluppo delle capacità di produzione e rafforzamento della catena di approvvigionamento
- Stabilire partnership chiave
- Implementazione di riallineamenti del personale
- Snellimento dei processi aziendali
- Formalizzazione dei flussi di lavoro e standardizzazione delle procedure
Il CEO Adam Sachs ha riconosciuto il ruolo di Clark nella costruzione di una solida base per la crescita futura. Clark continuerà a fornire orientamenti strategici come Membro del Consiglio, assicurando che la sua esperienza rimanga disponibile per l'azienda, consentendo al contempo un'evoluzione della leadership allineata con le esigenze strategiche e di capitale.
Vicarious Surgical (NYSE: RBOT) anunció que el Presidente de la Compañía, Randy Clark, pasará a un rol de Miembro de la Junta, efectivo el 25 de abril de 2025. Como Presidente, Clark lideró funciones empresariales clave, incluyendo el desarrollo de productos, operaciones, regulación clínica, asuntos de calidad y recursos humanos.
Durante su mandato, Clark hizo contribuciones significativas al:
- Desarrollar capacidades de fabricación y fortalecer la cadena de suministro
- Establecer asociaciones clave
- Implementar reajustes de personal
- Optimizar procesos empresariales
- Formalizar flujos de trabajo y estandarizar procedimientos
El CEO Adam Sachs reconoció el papel de Clark en la construcción de una base sólida para el crecimiento futuro. Clark continuará proporcionando orientación estratégica como Miembro de la Junta, asegurando que su experiencia siga disponible para la empresa mientras permite la evolución del liderazgo alineada con las necesidades estratégicas y de capital.
Vicarious Surgical (NYSE: RBOT)는 회사의 사장인 랜디 클락이 2025년 4월 25일부터 이사회의 멤버로 전환될 것이라고 발표했습니다. 사장으로서 클락은 제품 개발, 운영, 임상 규제, 품질 관리 및 인사 관리 등 주요 비즈니스 기능을 이끌었습니다.
그의 재임 기간 동안, 클락은 다음과 같은 중요한 기여를 했습니다:
- 제조 능력 개발 및 공급망 강화
- 주요 파트너십 구축
- 인력 재조정 시행
- 비즈니스 프로세스 간소화
- 업무 흐름 공식화 및 절차 표준화
CEO 아담 삭스는 클락이 미래 성장의 강력한 기반을 구축하는 데 기여한 역할을 인정했습니다. 클락은 이사로서 전략적 지침을 계속 제공하며, 그의 전문성이 회사에 계속 제공될 수 있도록 하면서 전략적 및 자본적 필요에 맞춰 리더십의 진화를 허용할 것입니다.
Vicarious Surgical (NYSE: RBOT) a annoncé que le Président de l'Entreprise, Randy Clark, passera à un rôle de Membre du Conseil d'Administration, à compter du 25 avril 2025. En tant que Président, Clark a dirigé des fonctions commerciales clés, y compris le développement de produits, les opérations, la réglementation clinique, les affaires de qualité et les ressources humaines.
Au cours de son mandat, Clark a apporté des contributions significatives en :
- Développant des capacités de fabrication et renforçant la chaîne d'approvisionnement
- Établissant des partenariats clés
- Mettant en œuvre un réalignement du personnel
- Rationalisant les processus d'affaires
- Formaliser les flux de travail et standardiser les procédures
Le PDG Adam Sachs a reconnu le rôle de Clark dans la construction d'une base solide pour la croissance future. Clark continuera à fournir des conseils stratégiques en tant que membre du Conseil, garantissant que son expertise reste disponible pour l'entreprise tout en permettant une évolution du leadership alignée sur les besoins stratégiques et de capital.
Vicarious Surgical (NYSE: RBOT) gab bekannt, dass der Unternehmenspräsident Randy Clark ab dem 25. April 2025 in eine Rolle als Mitglied des Vorstands wechseln wird. Als Präsident leitete Clark wichtige Geschäftsbereiche, darunter Produktentwicklung, Betrieb, klinische Regulierung, Qualitätsangelegenheiten und Personalwesen.
Während seiner Amtszeit leistete Clark bedeutende Beiträge durch:
- Entwicklung von Produktionskapazitäten und Stärkung der Lieferkette
- Aufbau wichtiger Partnerschaften
- Implementierung von Personalneuausrichtungen
- Optimierung von Geschäftsprozessen
- Formalisation von Arbeitsabläufen und Standardisierung von Verfahren
CEO Adam Sachs erkannte Clarks Rolle beim Aufbau einer soliden Grundlage für zukünftiges Wachstum an. Clark wird weiterhin strategische Beratung als Vorstandsmitglied bieten und sicherstellen, dass seine Expertise dem Unternehmen zur Verfügung steht, während er gleichzeitig eine evolutionäre Führung im Einklang mit strategischen und kapitalbedingten Bedürfnissen ermöglicht.
- Retention of experienced leadership expertise through Board position
- Successful establishment of manufacturing capabilities and supply chain partnerships
- Implementation of streamlined business processes and standardized procedures
- Leadership restructuring may create temporary operational adjustments
- Transition period could impact ongoing strategic initiatives
As President, Mr. Clark directed critical business functions, including product development, operations, clinical regulatory, quality affairs, and human resources. He spearheaded the strategic development of Vicarious Surgical’s manufacturing capabilities, establishing key partnerships and strengthening the supply chain. Notably, he implemented key personnel realignment, streamlined business processes, and formalized workflows and standardized procedures in order to position the Company for its next phase of growth.
“Under Randy’s leadership as President, Vicarious Surgical has made significant strides in building a strong foundation for future growth,” said Adam Sachs, Co-founder and Chief Executive Officer. “We are incredibly grateful for his dedication and are delighted that he will continue to contribute his invaluable expertise and strategic vision as a member of our Board of Directors. This transition allows us to retain his insights while evolving our leadership structure to best serve the Company's strategic and capital needs.”
Mr. Clark stated, “I want to express my sincere gratitude to the Vicarious Surgical team and Board. I am incredibly proud of what we have accomplished together, and for that, Vicarious Surgical is now exceptionally well-positioned to execute its strategy and achieve its milestones. It's precisely because of this strong foundation that I feel comfortable transitioning to a new role, knowing I'll remain a part of the Vicarious Surgical journey, supporting the Company in a different capacity as we move forward.”
About Vicarious Surgical
Founded in 2014, Vicarious Surgical is a next-generation robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to virtually transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. All statements other than statements of historical facts contained herein, are forward-looking statements that reflect the current beliefs and expectations of management. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside Vicarious Surgical’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the ability to maintain the listing of Vicarious Surgical’s Class A common stock on the New York Stock Exchange; the approval, commercialization and adoption of Vicarious Surgical’s initial product candidates and the success of its single-port surgical robot, called the Vicarious Surgical System, and any of its future product candidates and service offerings; changes in applicable laws or regulations; the ability of Vicarious Surgical to raise financing in the future; the success, cost and timing of Vicarious Surgical’s product and service development activities; the potential attributes and benefits of Vicarious Surgical’s product candidates and services; Vicarious Surgical’s ability to obtain and maintain regulatory approval for the Vicarious Surgical System, and any related restrictions and limitations of any approved product; the size and duration of human clinical trials for the Vicarious Surgical System; Vicarious Surgical’s ability to identify, in-license or acquire additional technology; Vicarious Surgical’s ability to maintain its existing license, manufacture, supply and distribution agreements; Vicarious Surgical’s ability to compete with other companies currently marketing or engaged in the development of products and services that Vicarious Surgical is currently marketing or developing; the size and growth potential of the markets for Vicarious Surgical’s product candidates and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of Vicarious Surgical’s product candidates and services and reimbursement for medical procedures conducted using its product candidates and services; the Company’s estimates regarding expenses, revenue, capital requirements and needs for additional financing; Vicarious Surgical’s financial performance; economic downturns, political and market conditions and their potential to adversely affect Vicarious Surgical’s business, financial condition and results of operations; Vicarious Surgical’s intellectual property rights and its ability to protect or enforce those rights, and the impact on its business, results and financial condition if it is unsuccessful in doing so; and other risks and uncertainties indicated from time to time in Vicarious Surgical’s filings with the SEC. Vicarious Surgical cautions that the foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vicarious Surgical does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250324187770/en/
Investor Contact
Kaitlyn Brosco
Vicarious Surgical
Kbrosco@vicarioussurgical.com
Media Inquiries
media@vicarioussurgical.com
Source: Vicarious Surgical Inc.
FAQ
When will Randy Clark transition from President to Board Member at Vicarious Surgical (RBOT)?
What were Randy Clark's main achievements as President of Vicarious Surgical (RBOT)?
How will Randy Clark's transition affect Vicarious Surgical's (RBOT) leadership structure?
What departments did Randy Clark oversee as President of Vicarious Surgical (RBOT)?
